GPC3 and hepatocellular carcinoma: Studies have reported that the level of serum Glypican-3 (GPC3) in HCC patients is increased, which can accurately distinguish early HCC from cirrhosis, which secsitivity around 50%–72% (Hippo et al., 2004).